# TRICHLORMETHIAZIDE W/ RESERPINE
> **ANDA085248** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1983-04-13
## Drug
- **FDA Application Number:** ANDA085248
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRICHLORMETHIAZIDE W/ RESERPINE
- **Generic name:** Reserpine
- **Active ingredients:** RESERPINE; TRICHLORMETHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WATSON LABS
- **First approval:** 1983-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085248)
---
*MORVS · CC0 1.0*